Understanding the patient’s perspective is essential to driving the success of clinical trials, accelerating regulatory approvals, and enhancing the patient experience throughout their healthcare journey. Yet, amidst a challenging funding environment, empowered patients rightfully demanding greater involvement in treatment decisions, and regulatory bodies requiring transparent reporting of patient engagement activities, it has become
more critical than ever to establish quantitative measures for assessing the impact of these initiatives.

Despite this, a standardized approach to measuring the success of patient engagement strategies has yet to emerge. While patient affairs professionals recognize that meaningful engagement leads to treatments that better align with the needs of patients, the pharmaceutical industry has struggled to clearly demonstrate the value of patient engagement to all stakeholders. To ensure patient engagement remains a cornerstone of healthcare innovation, the industry must adopt a unified framework for measuring its value and impact.

The 2nd Measuring Patient Engagement Summit 2025 aimed to address this critical challenge. This transformative event brings together leading experts in Patient Engagement, Advocacy, Affairs, Experience, Insights, Marketing, and beyond to share actionable case studies on how to quantitatively and objectively measure patient engagement. By standardizing these approaches, participants will gain the tools they need to demonstrate the value of their initiatives to both internal and external stakeholders, ensuring patient engagement remains a strategic priority across the product development lifecycle and therapeutic landscapes.

Driving the future of patient-centered innovation—because when we measure what matters, we create a healthcare system that truly works for everyone.